CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 84  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0572
LYS 10.0267
GLU 20.0572
LEU 30.0244
ARG 40.0409
CYS 50.0254
GLN 60.0256
CYS 70.0240
ILE 80.0151
LYS 90.0411
THR 100.0116
TYR 110.0050
SER 120.0123
LYS 130.0102
PRO 140.0093
PHE 150.0042
HIS 160.0114
PRO 170.0095
LYS 180.0080
PHE 190.0165
ILE 200.0047
LYS 210.0230
GLU 220.0135
LEU 230.0064
ARG 240.0085
VAL 250.0028
ILE 260.0097
GLU 270.0077
SER 280.0053
GLY 290.0105
PRO 300.0336
HIS 310.0202
CYS 320.0083
ALA 330.0341
ASN 340.0135
THR 350.0202
GLU 360.0195
ILE 370.0110
ILE 380.0109
VAL 390.0089
LYS 400.0153
LEU 410.0141
SER 420.0209
ASP 430.0182
GLY 440.0089
ARG 450.0254
GLU 460.0283
LEU 470.0160
CYS 480.0132
LEU 490.0063
ASP 500.0059
PRO 510.0135
LYS 520.0232
GLU 530.0089
ASN 540.0056
TRP 550.0154
VAL 560.0077
GLN 570.0208
ARG 580.0268
VAL 590.0142
VAL 600.0149
GLU 610.0139
LYS 620.0103
PHE 630.0103
LEU 640.0189
LYS 650.0201
ARG 660.0082
ALA 670.0283
GLU 680.0277
ASN 690.0239

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.